Home Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform
 

Keywords :   


Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform

2016-03-30 06:19:04| drugdiscoveryonline Home Page

Librede, a biotechnology company specializing in yeast-based cannabinoid production, announced that it has received a Small Business Innovative Research (SBIR) grant from the National Center for Complementary & Integrative Health (NCCIH) of the National Institutes of Health (NIH)

Tags: production develop drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
02.06Weekly Recap: Dyper Names CEO, Soft N Dry Diapers Expand Distribution to Brazil & More
02.06Atlantic Tropical Weather Outlook
02.06Eastern North Pacific Tropical Weather Outlook
02.06Shops rush for Christmas stock as shipping costs surge
02.06Successful entrepreneurs dont worry about being different
02.06Eastern North Pacific Tropical Weather Outlook
More »